Article Correctness Is Author's Responsibility: Trials for Investigational Alzheimer’s Tx Lanabecestat Discontinued

The article below may contain offensive and/or incorrect content.

Phase 3 clinical trials for lanabecestat (Eli Lilly and AstraZeneca), an investigational Alzheimer disease treatment, are being discontinued for futility.